Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 6 studies | 26% ± 6% |
Insufficient scRNA-seq data for expression of PLAAT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 93% | 68.84 | 425 / 459 | 85% | 21.58 | 953 / 1118 |
kidney | 100% | 205.35 | 89 / 89 | 62% | 4.67 | 555 / 901 |
lung | 98% | 121.98 | 569 / 578 | 61% | 9.81 | 699 / 1155 |
stomach | 84% | 219.86 | 302 / 359 | 68% | 8.48 | 195 / 286 |
intestine | 77% | 242.33 | 748 / 966 | 67% | 8.43 | 351 / 527 |
ovary | 64% | 7.08 | 116 / 180 | 70% | 7.19 | 299 / 430 |
liver | 85% | 37.00 | 193 / 226 | 39% | 5.95 | 160 / 406 |
esophagus | 49% | 6.96 | 713 / 1445 | 62% | 7.05 | 114 / 183 |
thymus | 84% | 13.04 | 551 / 653 | 22% | 0.78 | 136 / 605 |
bladder | 43% | 3.76 | 9 / 21 | 50% | 13.29 | 253 / 504 |
pancreas | 9% | 0.78 | 31 / 328 | 80% | 20.81 | 143 / 178 |
prostate | 75% | 14.15 | 184 / 245 | 13% | 0.51 | 64 / 502 |
spleen | 79% | 15.17 | 190 / 241 | 0% | 0 | 0 / 0 |
adipose | 77% | 9.71 | 932 / 1204 | 0% | 0 | 0 / 0 |
uterus | 31% | 5.69 | 52 / 170 | 45% | 5.45 | 207 / 459 |
brain | 62% | 6.87 | 1639 / 2642 | 3% | 0.13 | 23 / 705 |
peripheral blood | 53% | 43.74 | 495 / 929 | 0% | 0 | 0 / 0 |
skin | 47% | 8.30 | 851 / 1809 | 0% | 0.00 | 1 / 472 |
blood vessel | 46% | 4.22 | 612 / 1335 | 0% | 0 | 0 / 0 |
heart | 41% | 3.89 | 353 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 29% | 1.79 | 13 / 45 |
adrenal gland | 18% | 1.25 | 46 / 258 | 0% | 0 | 0 / 230 |
muscle | 10% | 0.76 | 78 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.47 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070292 | Biological process | N-acylphosphatidylethanolamine metabolic process |
GO_0036152 | Biological process | phosphatidylethanolamine acyl-chain remodeling |
GO_0016042 | Biological process | lipid catabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0004623 | Molecular function | phospholipase A2 activity |
GO_0016410 | Molecular function | N-acyltransferase activity |
GO_0008970 | Molecular function | phospholipase A1 activity |
GO_0016746 | Molecular function | acyltransferase activity |
GO_0052739 | Molecular function | phosphatidylserine 1-acylhydrolase activity |
GO_0052740 | Molecular function | 1-acyl-2-lysophosphatidylserine acylhydrolase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PLAAT2 |
Protein name | Phospholipase A and acyltransferase 2 (EC 2.3.1.-) (EC 3.1.1.32) (EC 3.1.1.4) (HRAS-like suppressor 2) |
Synonyms | HRASLS2 |
Description | FUNCTION: Exhibits both phospholipase A1/2 and acyltransferase activities . Shows phospholipase A1 (PLA1) and A2 (PLA2) activity, catalyzing the calcium-independent release of fatty acids from the sn-1 or sn-2 position of glycerophospholipids . For most substrates, PLA1 activity is much higher than PLA2 activity . Shows O-acyltransferase activity, catalyzing the transfer of a fatty acyl group from glycerophospholipid to the hydroxyl group of lysophospholipid . Shows N-acyltransferase activity, catalyzing the calcium-independent transfer of a fatty acyl group at the sn-1 position of phosphatidylcholine (PC) and other glycerophospholipids to the primary amine of phosphatidylethanolamine (PE), forming N-acylphosphatidylethanolamine (NAPE), which serves as precursor for N-acylethanolamines (NAEs) . Catalyzes N-acylation of PE using both sn-1 and sn-2 palmitoyl groups of PC as acyl donor . Exhibits high phospholipase A1/2 activity and low N-acyltransferase activity . . |
Accessions | ENST00000255695.2 Q9NWW9 |